Treace Medical Reports Q1 2026 Earnings: Revenue Declines, Net Loss Widens
Treace Medical (TMCI) reported first-quarter revenue of $47.2 million for the period ending March 31, 2026, a 10% decrease year-over-year due to shifts in product mix and lower kit sales. The company posted a net loss of $18 million or $0.28 per share compared to $15.9 million last year.
Tickers: $TMCI
Topics: cash_position ebitda gross_margin guidance net_loss operating_expenses revenue